New Antidepressant Prescriptions Before, During, and After the COVID-19 Pandemic: Sex and Age Differences in a Population-Based Ecological Study

Healthcare, Journal Year: 2025, Volume and Issue: 13(5), P. 502 - 502

Published: Feb. 26, 2025

Purpose: It is well established that the COVID-19 pandemic has increased incidence of depressive symptoms in general population. So far, there are no studies analyzing how this affected prescription antidepressants. Methods: We retrospectively estimated new cases depression by prescriptions antidepressive agents over a period 6 years distributed three periods 2 each: pre-pandemic, pandemic, and post-pandemic, running from March 2018 to February 2024. This research was conducted healthcare area with 130,000 individuals Spain. Results: New for antidepressants significantly during even more post-pandemic period, increase being greater women than men. During specifically due an among people under 20 age, while occurred all age groups. In subgroup analysis, we found exclusively number aged 40 or who were prescribed antidepressant, been significant both male female patients antidepressant groups compared two previous periods, except young men up years. Conclusions: Our study highlights importance addressing mental health population parallel physical problems adapting systems accordingly.

Language: Английский

Transitions in Mental Health Care Utilization at GHU Paris Between 2019 and 2024: A Post-Pandemic Perspective

Psychiatry Research, Journal Year: 2025, Volume and Issue: unknown, P. 116482 - 116482

Published: April 1, 2025

This study aimed to analyse the long-term evolution of mental health services use following COVID-19 pandemic. was a retrospective study, conducted from 2019 2024, using Groupe Hospitalier Universitaire Paris Psychiatry and Neurosciences (GHU Paris) databases. We considered number patients consulting at GHU clinics, presenting emergency department (ED), hospital admissions per week, by sex age group. performed piecewise linear regression, threshold approach identify time patterns between 2024: pre-pandemic period (T1), short-term (T2) post-pandemic (T3). Temporal changes in healthcare service were then analysed. No significant overall observed outpatients after pandemic, except for slight increase among aged 15-24 years. The remained lower 2024 compared with 2019, decreasing trend T3 all subgroups. In contrast, ED visits increased over time, higher women young people 2019. (T3) continued show an increasing pattern. Additionally, reduction schizophrenia presentations observed, while there substance or neurotic disorders. Our results described transitions highlighting reduced admissions, psychiatric emergencies, reasons seeking care.

Language: Английский

Impact of COVID-19 Pandemic on Consumption of Anxiolytics, Antipsychotics, and Antidepressants in South Italian Region

Life, Journal Year: 2025, Volume and Issue: 15(4), P. 652 - 652

Published: April 16, 2025

The COVID-19 lockdown had significant consequences on the mental health of millions people, leading to increasing prescription and use psychotropic drugs. Due lack data in current literature, this study aims estimate trends consumption anxiolytics, antipsychotics, antidepressants before during pandemic people South Italian region. We conducted a retrospective observational study, retrieving prescriptions dispensed pharmacies Basilicata region (South Italy) for period 2019–2021. presented data, expressed Daily Defined Doses (DDDs) 1000 persons/day (DHD), total resident population 95,021, dividing age groups into categories <30, 30–50, 50–70, >70 years. linear regression model examinate across Software XLSTAT was used statistical analysis. During period, more than 85,000 boxes medications were dispensed. research showed an increase sales all three drugs examined, with greater rise benzodiazepines (88.5%) selective serotonin reuptake inhibitors (81.9%) 2021 compared 2019, especially among women under 30 led drugs, confirming impact population’s health.

Language: Английский